These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19883161)

  • 1. Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?
    Olcén P; Fredlund H
    Scand J Infect Dis; 2010; 42(1):4-11. PubMed ID: 19883161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection and characterization of Neisseria meningitidis.
    Taha MK
    Expert Rev Mol Diagn; 2002 Mar; 2(2):143-50. PubMed ID: 11962334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for controlling invasive meningococcal disease in high income countries.
    Holst J; Nøkleby H; Bettinger JA
    Vaccine; 2012 May; 30 Suppl 2():B57-62. PubMed ID: 22607900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.
    Jacobsson S; Thulin S; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
    Vaccine; 2006 Mar; 24(12):2161-8. PubMed ID: 16321460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group-C meningococcal conjunctivitis in a neonate.
    Dinakaran S; Desai SP
    Ocul Immunol Inflamm; 2000 Jun; 8(2):123-5. PubMed ID: 10980686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of invasive meningococcal disease in the Czech Republic.
    Kriz P
    Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal protein antigens and vaccines.
    Feavers IM; Pizza M
    Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines.
    Diggle MA; Clarke SC
    J Clin Microbiol; 2005 Sep; 43(9):4649-53. PubMed ID: 16145121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postgenomics of Neisseria meningitidis for vaccines development.
    Bernardini G; Braconi D; Martelli P; Santucci A
    Expert Rev Proteomics; 2007 Oct; 4(5):667-77. PubMed ID: 17941821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of group B meningococcal disease by vaccination: a difficult task.
    Thomas M
    N Z Med J; 2004 Aug; 117(1200):U1016. PubMed ID: 15475986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of meningococcal vaccines and their serological correlates of protection.
    Vipond C; Care R; Feavers IM
    Vaccine; 2012 May; 30 Suppl 2():B10-7. PubMed ID: 22607894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance snapshot: cases of service member meningococcal disease reported to the Naval Health Research Center Laboratory-based Meningococcal Disease Surveillance Program, 2006-2014.
    Broderick MP
    MSMR; 2014 Jul; 21(7):18. PubMed ID: 25080333
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
    Gorringe AR
    Expert Rev Vaccines; 2005 Jun; 4(3):373-9. PubMed ID: 16026250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.